Other treatments for lung cancer, such as immunotherapy and targeted therapies, can also cause severe skin rashes, dryness, and hyperpigmentation, according to a 2017 review of scientific literature.

People with small cell lung cancer (SCLC) may develop hyperpigmentation. This skin change is typically harmless, but people may choose to reduce its appearance with procedures such as laser ...

Merck Cancer Drug Shines Against Skin, Lung Cancer. ByMatthew Herper, Former Staff. I cover science and medicine, and believe this is biology's century. Apr 19, 2015, 09:00am EDT Apr 19, 2015, 08 ...

Finding cancer early makes it much more likely that treatment will work. There are early signs of cancer that are easy to ...

Here’s how they treat lung cancer. Skip to main content . Home ; Conditions . Back ... Opdivo Qvantig is the first medicine known as a PD-1 inhibitor that can be given under the skin instead of ...

Most skin cancers regress in response to inflammation and since immunotherapies that provoke an inflammatory response have proven successful in melanoma, immunotherapies targeted at non-melanoma ...

The treatment plan and goal of treatment depend on the stage of your NSCLC, or how much the cancer has spread. Options for treatment include ...

A skin cancer vaccine, genetic tests, and AI photo apps can help detect, prevent, ... including non-small cell lung cancer, Eric Rubin, a senior vice president at Merck, ...